Archive for the ‘Eye Health / Optometry’ Category

best quality opticals starting from 8$

Friday, March 14th, 2008

Zenni Opticals offer best quality opticals starting from 8$ their Complete Single Vision Eyeglasses starting at $8.00 $ 8 Zenni Optical Rx Eyeglasses whats so great about them they offers free Anti Scratch coating, UV protection, Lens Edge polishing and Beveling :) they have opticals in many categories like Plastic starting from 19$ Stainless ...

Dr. Gabriel Sosne To Present New T?4 Anti-Inflammation Data At ARVO

Monday, March 3rd, 2008

Regenerx Biopharmaceuticals, Inc. (Amex:Rgn) announced that Dr. Gabriel Sosne, Assistant Professor of Ophthalmology at Wayne State University School of Medicine and the Kresge Eye Institute in Detroit, MI, will be presenting data from a new study entitled, "Lipid Rafts and Actin Are Important for Thymosin Beta 4-Mediated Anti-Inflammatory Effects in ...

Precautions Necessary To Avoid Risk Of Blindness After Ophthalmic Surgery

Tuesday, February 26th, 2008

Ophthalmologists inject gas into the eye mainly during the surgical treatment of retinal hemorrhages or injuries. The purpose of the gas is to help press the detached retina to the wall of the eye. There is a risk of subsequent expansion of the gas bubble during airplane travel, at high ...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study Of Xibrom(TM) Combination Therapy With Lucentis(R)

Saturday, February 23rd, 2008

ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the acceptance of an abstract describing the results of a study using Xibrom(TM) (bromfenac ophthalmic solution) 0.09% therapy in combination with Lucentis(R) (ranibizumab injection) in patients with age-related macular degeneration (AMD). According to the abstract, patients who received Xibrom required 1.6 +/- 0.69 injections ...

Identification Of Deficient Receptor That Causes Dry Form Of AMD Offers New Hope For Treatment Of Vision Loss

Thursday, February 21st, 2008

Scientists have won a major battle in the fight against age-related macular degeneration, or AMD, a blinding eye disease that affects millions of people. An international team, led by researchers at Sainte-Justine Hospital and the Universite de Montréal, has identified the deficient receptor that causes the dry form of AMD. In ...

Age-Related Macular Degeneration Discovery: New Hope For Treatment Of Vision Loss

Thursday, February 21st, 2008

Scientists have won a major battle in the fight against age-related macular degeneration, or AMD, a blinding eye disease that affects millions of people. An international team, led by researchers at Sainte-Justine Hospital and the Université de Montréal, has identified the deficient receptor that causes the dry form of AMD. In ...

Treatment Of Antibiotic Twice Per Year Reduces Infectious Blindness In Africa

Wednesday, February 20th, 2008

A recent article in The Journal of the American Medical Association reports that when preschool children in villages in Ethiopia took the antibiotic azithromycin twice per year instead of once per year, the number of children with eye infections caused by the contagious eye disease trachoma was significantly reduced. The ...

New Point Of View On Melanoma Of The Eye: HSP9

Wednesday, February 20th, 2008

Ocular melanoma is rarely detected before it has grown large enough to impair vision or to metastasize. This makes it a particularly challenging disease to fight, especially since chemotherapy is not very effective. Now, the PhD research project led by Dr. Dana Faingold may open the door for very promising new ...

U.S. Phase I Enrollment And Commence European Clinical Trial For The Argus II Retinal Implant Completed

Monday, February 18th, 2008

The University of Southern California (USC) and Second Sight Medical Products Inc, a leading developer of retinal prostheses for treating blindness, announced that they have completed enrollment of the first phase of a US FDA approved clinical study of the Argus II Retinal Prosthesis System. Second Sight also announced that ...